About Synthekine
Discovering, Developing and Commercializing the Next Generation of Selective Cytokine Therapeutics. We believe that cytokine therapeutics engineered to be selective can fundamentally change the treatment paradigm of cancer and inflammatory disease.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $100,000,000 · Series-B+
startupintros.com
- Capital Raise
Raised $108,000,000 · Series-B+
- Capital Raise
Raised $82,000,000 · Series-A
startupintros.com
- Milestone
X account created (@synthekine)
226 followers
- Milestone
Company founded
Menlo Park, United States
- Milestone
Website domain registered
synthekine.com
Investors & Backers
Funding History
Founders & Leadership
Press Coverage & Sources
startupintros.com/news/2023-01-01-synthekine-series-c
fundraisingfox.com/companies/synthekine
fiercebiotech.com/biotech/synthekine-scores-significant-series-b-to-secure-set-clinical-trials-12-months
startupintros.com/news/2020-09-01-synthekine-series-a
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com